A further patient received the ExoVasc® support in late September. For Professor John Pepper this successful operation on an 18-year old patient adds new data to the clinical trial. Results on the 12 – 48 month follow-up of the first group of patients in the trial are currently being analysed in preparation for the publication of a scientific paper.